Companies: 10,795·Total market cap: $144.5T
Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPDNASDAQHealthcare● Active
$0.49
$-0.01(-2.06%)
Market Cap$5432584
P/E Ratio—
52W High$2.58
52W Low$0.37
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Cellyan Biotechnology Co., Ltd (HKPD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0002007702 · HKPD · NASDAQ · as of Jun 8, 2026

Filing snapshot

50
Total Filings
EFFECT
Latest Form
2026-04-08
Most Recent
2025
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0002007702 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-08-14
Fiscal Year End
Aug 14, 2025
Accession No.
0001213900-25-076725
Primary Document
ea0252263-20f_hongkong.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0002007702 · Accession 0001213900-25-076725

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-27
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2026-04-08
View
CORRESPCORRESP
CORRESP
2026-04-06
View
UPLOADUPLOAD
UPLOAD
2026-04-02
View
F-1F-1
REGISTRATION STATEMENT
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-01-16
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-12-31
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-12-17
View
6-KCurrent Report (Foreign Issuer)
CURRENT REPORT
2025-11-24
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-11-12
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2025-11-12
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-10-07
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2025-09-11
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2025-08-14
View
Showing 1–15 of 50 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0002007702  |  Exchange: NASDAQ · Healthcare

Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD) has submitted 50 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Healthcare sector company with CIK 0002007702, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Cellyan Biotechnology Co., Ltd's most comprehensive regulatory disclosure. The most recent Cellyan Biotechnology Co., Ltd 10-K was filed on 2025-08-14 for fiscal year ending 2025. Historical HKPD 10-K annual reports are available from 2024 through 2025.

Investors researching Cellyan Biotechnology Co., Ltd SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CRGO SEC Filings →NCEW SEC Filings →PSIG SEC Filings →UUU SEC Filings →ARTW SEC Filings →TLIH SEC Filings →VRME SEC Filings →LSH SEC Filings →
→ HKPD Financials→ HKPD Earnings→ HKPD Insider Trades

Frequently Asked Questions

HKPD SEC Filings · 8 questions

Cellyan Biotechnology Co., Ltd (HKPD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 50 filings and access original documents at no cost. Cellyan Biotechnology Co., Ltd's CIK is 0002007702.

HKPD SEC filingsCellyan Biotechnology Co., Ltd SEC documentsfind HKPD 10-K